Business Context and Reporting Period
Company: Innovative Eyewear, Inc. (Ticker: LUCY)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 30, 2026
Business Overview: The Company develops and sells smart eyewear (prescription, sunglasses, safety, and sport glasses) under the Lucyd brand and co-branded lines (Nautica, Eddie Bauer, Reebok). Products enable hands-free connectivity via the Lucyd app, featuring AI integration (ChatGPT, Claude). Sales channels include e-commerce (Lucyd.co, Amazon) and a growing wholesale network.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2026 |
Six Months Ended June 30, 2026 |
|---|---|---|
| Revenues, Net | $1,010,519 | $1,784,080 |
| Gross Profit | $242,515 | $417,960 |
| Gross Margin | 24% | 23% |
| Net Loss | $(1,670,818) | $(3,980,186) |
| Loss Per Share (Basic/Diluted) | $(0.26) | $(0.63) |
| Cash and Cash Equivalents | $2,455,146 | $2,455,146 (Balance Sheet) |
| Total Liquidity (Cash + Investments) | $3,743,120 | $3,743,120 (Balance Sheet) |
| Working Capital | $6,222,907 | $6,222,907 (Balance Sheet) |
| Total Debt | $0 | $0 |
Material Changes vs. Prior Comparable Period
- Revenue Growth: Revenue increased 74% year-over-year (YoY) for the quarter and 73% YoY for the six-month period. Growth was driven by a 73% increase in unit volumes, specifically the Lucyd Armor safety glasses (approx. 4,700 units sold in Q2) and Reebok co-branded lines.
- Margin Improvement: Gross margin rebounded to 24% in Q2 2026 from a -2% deficit in Q2 2025. This improvement is attributed to successful mitigation of tariff impacts and economies of scale in sourcing.
- Operating Expenses: Total operating expenses decreased 10% YoY for the quarter, primarily due to a 47% reduction in R&D costs. However, G&A expenses increased on a six-month basis due to higher license agreement payments.
- Cash Position: Cash and cash equivalents decreased from $6.5 million at year-end 2025 to $2.5 million at June 30, 2026, reflecting operating cash outflows of $4.35 million for the six-month period.
Guidance, Outlook, and Risks
- Outlook: Management expects continued revenue growth in the second half of 2026, driven by the new Reebok optical collection, a partnership with FYihealth group (345 Canadian clinics), and a 50-store test with a major U.S. retailer commencing in October 2026.
- Liquidity: The Company raised approximately $1.4 million net via at-the-market offerings in the first half of 2026. Subsequent to the reporting period (July 2026), the Company raised approximately $3.0 million gross via a warrant inducement transaction. Management believes current liquidity plus available related-party borrowing is sufficient for the next 12 months.
- Risks:
- Tariffs: Ongoing uncertainty regarding international trade and tariffs remains a material risk, though management has taken steps to mitigate impacts.
- Internal Controls: The Company disclosed material weaknesses in internal control over financial reporting, rendering disclosure controls and procedures ineffective as of June 30, 2026.
- License Obligations: The Company has significant future minimum royalty payments under multi-year license agreements (approx. $12.8 million total), with $1.29 million due in 2027.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of the 74% revenue growth and the specific contribution of the Lucyd Armor and Reebok lines versus legacy products.
- Tariff Exposure: Assess the long-term viability of gross margins given the fluid geopolitical climate and potential for retaliatory tariffs.
- Liquidity Runway: Confirm the utilization of the $3.0 million raised in July 2026 and the sufficiency of cash to cover the $1.29 million license payment due in 2027.
- Internal Controls: Review the remediation plan for the disclosed material weaknesses in internal controls over financial reporting.
- Related Party Transactions: Monitor the $35,000 quarterly management fee to Tekcapital and the terms of the related-party loan facilities.